Kenvue Inc.
KVUE
Pozycja w akcjach
#630
Kenvue Inc. functions as a global leader in the consumer health sector. The... Kenvue Inc. functions as a global leader in the consumer health sector. The company structures its operations across three primary divisions: Self Care, Skin Health and Beauty, and Essential Health. Within the Self Care unit, it offers a diverse range of products for common conditions like coughs, colds, and allergies, in addition to pain relief, digestive health, and smoking cessation aids, featuring prominent brands such as Tylenol, Nicorette, and Zyrtec. The Skin Health and Beauty segment delivers various solutions for facial, body, hair, and sun protection, recognized under popular labels including Neutrogena, Aveeno, and OGX. Moreover, the Essential Health category provides oral hygiene, infant care, feminine wellness, and wound treatment products, marketed through esteemed brands like Listerine, Johnson's, Band-Aid, and Stayfree. Established in 2022, Kenvue Inc. maintains its corporate headquarters in Skillman, New Jersey, and operates as a subsidiary of Johnson & Johnson.
Cena akcji
$19.68
Kapitalizacja rynkowa
$37.79B
Zmiana (1 dzień)
3.25%
Zmiana (1 rok)
29.53%
Kraj
US
Handel Kenvue Inc. (KVUE)
Kategoria
Consumer Defensive
Historia ceny akcji dla Kenvue Inc. (KVUE)
Najwyższa cena zamknięcia: $18.15 dnia 2026-10-01
Najniższa cena zamknięcia: $26.47 dnia 2023-05-01
Najniższa cena zamknięcia: $26.47 dnia 2023-05-01
Historia cen akcji firmy Kenvue Inc. od 2023 do 2026
Roczna wydajność ceny akcji
| Rok | Wydajność |
|---|---|
| 2026 (TTM) | 3.72% |
| 2025 | -23.00% |
| 2024 | 6.28% |
| 2023 | 0.00% |
Cena akcji podobnych firm lub konkurencji
| Firma | Cena akcji | Zmiana 1r% | Kraj |
|---|---|---|---|
| $166.29 | 9.26% |
US
|
|
| $462.06 | 7.15% |
FR
|
|
| $97.26 | 21.79% |
US
|
|
| $19.25 | -34.64% |
IN
|
|
| $107.15 | 8.63% |
US
|
